<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04602403</url>
  </required_header>
  <id_info>
    <org_study_id>tamsulosin and uretroscopy</org_study_id>
    <nct_id>NCT04602403</nct_id>
  </id_info>
  <brief_title>Does Tamsulosin Facilitate Semi-rigid Ureteroscopic</brief_title>
  <official_title>Does Preoperative Tamsulosin Facilitate Semi-rigid Ureteroscopic Management of Lower Ureteric Calculi Prospective, Randomized Double Blind Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Ureteric calculi are one of the most common reasons for frequent Urolithiasis. The estimated&#xD;
      prevalence is 8-13% of all calculi.&#xD;
&#xD;
      Medical expulsive therapy (MET) is recommended by the European Association of Urology (EAU)&#xD;
      (2013) for 5-10 mm ureteric stones to facilitate stone passage. For MET, alpha blockers,&#xD;
      mainly tamsulosin, have shown efficacy in several randomized controlled trials. The&#xD;
      underlying pathophysiology of this therapy is supported by the presence and distribution of&#xD;
      adrenoreceptors in the ureter. Blocking the action of alpha-1 receptors by pharmacological&#xD;
      agents (alpha blockers), such as alfuzosin, terazosin, doxazosin, and, most typically,&#xD;
      tamsulosin, results in the relaxation of the ureteric smooth muscle.&#xD;
&#xD;
      Ureteroscopy (URS) is the most commonly performed procedure for the treatment of ureteral&#xD;
      calculi, with a high (&gt;90%) stone-free rate after a single treatment. Advancing a rigid&#xD;
      ureteroscope into a non-dilated ureter may be difficult and cause complications. Ureteric&#xD;
      dilatation may provide access to stones, but not in all cases, and ureteral mucosal injury up&#xD;
      to perforation might occur.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Based on the role of alpha blockers, mainly tamsulosin, in MET of ureteric calculus, the&#xD;
      investigator will attempt to extend the use of alpha blockers prior to URS for procedural&#xD;
      ease. the investigator will conduct a prospective, randomized double-blind study to evaluate&#xD;
      whether alpha blockers facilitate the negotiation of the ureteroscope if administered&#xD;
      preoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 15, 2020</start_date>
  <completion_date type="Anticipated">October 15, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 15, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of patients develop spontaneous expulsion of stone</measure>
    <time_frame>up to 3 weeks pre operative</time_frame>
    <description>the stone spontaneously expelled without intervension</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients showing dilated ureteric orifice</measure>
    <time_frame>intraoperative</time_frame>
    <description>during ureteroscopy easy introduction in the ureter</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients need dilatation below stone</measure>
    <time_frame>intraoperative</time_frame>
    <description>difficult introduce the ureteroscope and reach the stone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Number of patients need dormia extraction or forceps without disintegration</measure>
    <time_frame>intraoperative</time_frame>
    <description>that is due to dilated ureter so easy remove the stone</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Time of operation from introduction of ureteroscope until stone extraction</measure>
    <time_frame>intraoperative</time_frame>
    <description>to know how easy introduction and expulsion of the ureteroscope</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of patients developed side effect from tamsulosin</measure>
    <time_frame>up to 3 weeks pre operative</time_frame>
    <description>any side effect from alpha blocker</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of patients developed complication</measure>
    <time_frame>intraoperative</time_frame>
    <description>any compliction during ureteroscopy such as perforation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients show failure of ureteroscopy</measure>
    <time_frame>intraoperative</time_frame>
    <description>failed introduction or extraction of stone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of patients show residual stone post ureteroscopy</measure>
    <time_frame>postoperative 4 weeks</time_frame>
    <description>difficulty in expulsion of all stones</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Ureter Stone</condition>
  <arm_group>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>people who given placebo to become agroup of comparison with the other group</description>
  </arm_group>
  <arm_group>
    <arm_group_label>tamsulosin group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>people who given tamsulosin to know the effect on ureteroscopy and compare with the control group</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>rigid ureteroscopy</intervention_name>
    <description>endoscopic treatment of ureteric stones by extraction or peumatic desintegration or laser</description>
    <arm_group_label>placebo group</arm_group_label>
    <arm_group_label>tamsulosin group</arm_group_label>
    <other_name>endoscopic treatment of ureteric stone</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Lower ureteral stone.&#xD;
&#xD;
          -  Age: 18 - 75 years.&#xD;
&#xD;
          -  normal renal function.&#xD;
&#xD;
          -  single sided ureteral stone with normal other kideny.&#xD;
&#xD;
          -  sign the informed consent.&#xD;
&#xD;
          -  Be willing/able to adhere to follow up visits.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Upper and middle ureteral stones.&#xD;
&#xD;
          -  renal impairment.&#xD;
&#xD;
          -  Age &lt; 18 years or 75 &lt; years.&#xD;
&#xD;
          -  female who were pregnant&#xD;
&#xD;
          -  bilateral ureteric stone or solitary kidney.&#xD;
&#xD;
          -  urinary tract infection need drainage.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>ahmed m abdel hamed</last_name>
    <role>Study Director</role>
    <affiliation>Assiut University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>mahmoud a gaber</last_name>
    <phone>+201129248656</phone>
    <email>aboshika52@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Mahmoud Ahmed Gaber</name>
      <address>
        <city>Asyūţ</city>
        <state>Assiut</state>
        <zip>71511</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>mahmoud a gaber, ph</last_name>
      <phone>+201129248656</phone>
      <email>aboshika52@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>October 2020</verification_date>
  <study_first_submitted>October 15, 2020</study_first_submitted>
  <study_first_submitted_qc>October 20, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>October 20, 2020</last_update_submitted>
  <last_update_submitted_qc>October 20, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Mahmoud Ahmed Gaber</investigator_full_name>
    <investigator_title>Assistant Lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ureteral Calculi</mesh_term>
    <mesh_term>Ureterolithiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

